Investigating Incidental Pulmonary Nodules in Underserved Communities
NCT05738031 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2023-11-18
Summary
The study team hypothesizes that incidentally discovered pulmonary nodules are often under captured and/or not surveilled in accordance with published guidelines in the Montefiore Health System, which cares for a large proportion of Black and Hispanic patients. Incidental Pulmonary Nodules (IPNs) require a pragmatic approach to follow-up and management, especially in racially disparate populations who have greater potential for lung cancer morbidity and mortality.
Conditions
- Lung; Node
Sponsors & Collaborators
-
Montefiore Medical Center
lead OTHER
Principal Investigators
-
Neel Chudgar, MD · Montefiore Medical Center
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-10-31
- Primary Completion
- 2025-05-31
- Completion
- 2025-05-31
Countries
- United States
Study Locations
More Related Trials
-
The Relationship Between GOLD Risk Group and Clinical Outcomes in a Community-based COPD Cohort
NCT02838108 ·Status: TERMINATED
-
Evaluation of Patients With Idiopathic Pulmonary Fibrosis (IPF) Through an IPF Registry
NCT00212511 ·Status: WITHDRAWN
-
A Study of the Natural Progression of Interstitial Lung Disease (ILD)
NCT00470327 ·Status: RECRUITING
-
Detection of Early Idiopathic Pulmonary Fibrosis
NCT03457935 ·Status: ACTIVE_NOT_RECRUITING
-
Study of Progression to Progressive Fibrosing Interstitial Lung Disease (PF-ILD) Incidence/Management and Treatment
NCT05875532 ·Status: COMPLETED
-
A Study to Characterize the Disease Behavior of Idiopathic Pulmonary Fibrosis (IPF) and Interstitial Lung Disease (ILD) During the Peri-Diagnostic Period
NCT03261037 ·Status: COMPLETED ·Phase: NA
-
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
NCT01915511 ·Status: RECRUITING
-
Dose Reduction and Discontinuation With Anti-Fibrotic Medications
NCT05779007 ·Status: COMPLETED
-
68Ga-DOTA-NOC PET/CT in Patients With Idiopathic Pulmonary Fibrosis
NCT01321996 ·Status: TERMINATED ·Phase: PHASE4
-
PRospective Evaluation of Interstitial Lung DIsease Progression With Quantitative CT
NCT05609201 ·Status: ENROLLING_BY_INVITATION
-
Pulmonary Care and Research Collaborative Patient Registry
NCT05445817 ·Status: UNKNOWN
-
The Genetics of Pulmonary Fibrosis
NCT03478553 ·Status: RECRUITING
-
Influence of Socioeconomic and Environmental Factors on the Natural History of Idiopathic Pulmonary Fibrosis
NCT04619199 ·Status: UNKNOWN ·Phase: NA
-
A Multicenter Prospective Study of Risk Factors in Progressive Pulmonary Fibrosis
NCT05895409 ·Status: RECRUITING
-
Role of Genetic Factors in the Development of Lung Disease
NCT00001532 ·Status: RECRUITING
-
Natural History of Lung Nodules Seen on CT Scans From Participants at High-Risk of Developing Lung Cancer
NCT01540552 ·Status: COMPLETED
-
Diagnostic and Prognostic Model of Pulmonary Fibrosis After COVID-19 Pneumonia and Mechanism Study
NCT05719038 ·Status: UNKNOWN
-
Study on Screening Strategies for Interstitial Lung Abnormalities and Airway Lesions
NCT07023575 ·Status: NOT_YET_RECRUITING
-
Advancing Prevention of Pulmonary Fibrosis
NCT04564183 ·Status: ACTIVE_NOT_RECRUITING
-
Biomarkers of iNOS Activity in COPD, Asthma, Healthy Control
NCT00159302 ·Status: WITHDRAWN
-
Boston Early-Onset Chronic Obstructive Pulmonary Disease (COPD) Study
NCT01177618 ·Status: RECRUITING
-
Families-At-risk for Interstitial Lung Disease Study
NCT03641742 ·Status: COMPLETED
-
Optimising Screening for Early Disease Detection in Familial Pulmonary Fibrosis
NCT05367349 ·Status: UNKNOWN
-
Idiopathic Pulmonary Fibrosis Job Exposures Study
NCT03211507 ·Status: COMPLETED
-
Target Validation and Discovery in Idiopathic Bronchiectasis
NCT03750734 ·Status: COMPLETED